Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 94
Filter
1.
Eksp Onkol ; 8(2): 35-8, 70, 1986.
Article in Russian | MEDLINE | ID: mdl-3698881

ABSTRACT

It is shown that prodigiosan is an inductor of synthesis of the substances with the thymosin-like activity. The suggestion about inhibition of 3-methylcholanthrene-induced blastomogenesis by prodigiosan which is mediated by the substances with the thymosin-like activity and interferon is discussed. We present the hypothetical diagram of the development of the above mentioned mechanism. The significance of the obtained findings for elaboration of the immunotherapy is discussed.


Subject(s)
Interferon Inducers , Neoplasms, Experimental/chemically induced , Polysaccharides, Bacterial/therapeutic use , Prodigiozan/therapeutic use , Thymosin/biosynthesis , Animals , Drug Evaluation, Preclinical , Drug Synergism , Methylcholanthrene , Mice , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/mortality , Organ Size/drug effects , Rats , Spleen/drug effects , Thymectomy , Thymosin/blood , Thymus Gland/drug effects , Time Factors
2.
Radiats Biol Radioecol ; 34(4-5): 582-6, 1994.
Article in Russian | MEDLINE | ID: mdl-7951888

ABSTRACT

It was shown in experiments with mice and dogs that bacterial preparations (vaccinum proteus, prodigiosanum, bificolum and bificolum-f) administered before or after gamma-irradiation have a stimulating effect on hemopoiesis. It is supposed that bacterial polysaccharides play an important role in this action.


Subject(s)
Biological Products/therapeutic use , Hematopoiesis/drug effects , Radiation Injuries, Experimental/therapy , Acute Disease , Animals , Bacterial Vaccines/therapeutic use , Bacteriocins/therapeutic use , Dogs , Dose-Response Relationship, Radiation , Mice , Prodigiozan/therapeutic use , Proteus/immunology , Radiation Injuries, Experimental/blood , Time Factors
3.
Vestn Ross Akad Med Nauk ; (5): 36-41, 1996.
Article in Russian | MEDLINE | ID: mdl-8924825

ABSTRACT

The effects of hepatotropic growth factors (HGFs) and phospholipid drugs on the recovery of functions and the regeneration of the rat liver were studied in CC14-induced toxic damage and after partial hepatectomy (PHE). HGFs isolated from the cytoplasmic cells of the regenerating liver, as well as from the liver of the animals given prodigiozan and from the media taken after culturing the explants of the regenerating liver were found to stimulate DNA synthesis and hepatocytic proliferation following PHE and in the cirrhotic liver. Prodigiozan was shown to induce the formation of HGFs not only in the rat liver following PHE, but in the liver of intact animals. It was established that the covalently binding complex of albumin and bilirubin stimulated the synthesis of proteins and DNA in the regenerating liver, but non-covalently binding complex inhibited these processes. When CC14 was administered to the animals, the two complexes enhanced the reparative synthesis of DNA, without changing the level of replicating synthesis, the non-covalently binding complex completely eliminating the single-strand breaks in DNA. Phospholipid agents containing soybean and sunflower phosphatidylcholines increased the synthesis of RNA and albumin, which were decreased due to exposure to CC14 and had the property of stimulating the synthesis of total DNA and considerably enhancing that of mitochondrial DNA.


Subject(s)
Anti-Bacterial Agents/pharmacology , Chemical and Drug Induced Liver Injury/drug therapy , Hepatectomy , Hepatocyte Growth Factor/pharmacology , Liver Regeneration/drug effects , Liver/drug effects , Phosphatidylcholines/pharmacology , Prodigiozan/pharmacology , Animals , Anti-Bacterial Agents/therapeutic use , Carbon Tetrachloride/toxicity , Chemical and Drug Induced Liver Injury/etiology , DNA/biosynthesis , Helianthus , Hepatocyte Growth Factor/therapeutic use , Liver/metabolism , Liver/physiology , Liver Cirrhosis, Experimental/surgery , Phosphatidylcholines/therapeutic use , Prodigiozan/therapeutic use , RNA/biosynthesis , Rats , Glycine max
4.
Article in Russian | MEDLINE | ID: mdl-2870596

ABSTRACT

Experiments on 575 noninbred white mice have revealed that the nonspecific resistance of the animals to type A C. perfringens toxin can be enhanced by the administration of Prodigiosan, a commercial immunostimulating agent. Prodigiosan, introduced in 3-4 injections (the last one made 24 hours before intoxication) has been found to enhance the resistance of the animals to the subcutaneous injection of type A C. perfringens toxin by 40-60% and to its intraperitoneal injection by 60-97%.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Bacterial Toxins/immunology , Calcium-Binding Proteins , Clostridium perfringens , Gas Gangrene/immunology , Polysaccharides, Bacterial/therapeutic use , Prodigiozan/therapeutic use , Type C Phospholipases , Animals , Bacterial Toxins/antagonists & inhibitors , Drug Evaluation, Preclinical , Drug Resistance , Gas Gangrene/drug therapy , Gas Gangrene/mortality , Immunity, Innate/drug effects , Mice , Time Factors
5.
Article in Russian | MEDLINE | ID: mdl-2385993

ABSTRACT

The influence of prodigiosan, salmosan, polyribonate and levamisole on the body nonspecific and specific resistance to S. typhi strain 4446 has been studied. Prodigiosan and salmosan have proved to be the most effective. The injection of these compounds simultaneously with typhoid vaccine (both chemical adsorbed vaccine and alcohol-treated vaccine, enriched with Vi-antigen) significantly increases the survival rate of immunized animals (by 35-45%), elevates the resistance index (1.5- to 2.3-fold) and the effectiveness index of the vaccine (17- to 32-fold) in comparison with the controls. Besides, prodigiosan and salmosan alone are capable of increasing nonspecific resistance to S. typhi strain 4446, which is manifested by an increase of the survival rate of stimulated animals by 61.87%. Proceeding from the results thus obtained, the possibility of good prospects for prodigiosan and salmosan in the prophylaxis of typhoid fever in humans may be inferred.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Typhoid Fever/prevention & control , Animals , Drug Evaluation, Preclinical , Immunity, Innate/drug effects , Immunity, Innate/immunology , Male , Mice , Organic Chemicals , Polysaccharides, Bacterial/therapeutic use , Prodigiozan/therapeutic use , Salmonella typhi/drug effects , Salmonella typhi/immunology , Typhoid Fever/immunology , Typhoid Fever/mortality , Typhoid-Paratyphoid Vaccines/immunology
6.
Article in Russian | MEDLINE | ID: mdl-3364072

ABSTRACT

The immune and allergic status of patients with acute viral hepatitides A and B after treatment with prodigiosan, a bacterial lipopolysaccharide preparation, was studied. The drug produced as stimulating effect on cell-mediated and humoral immunity. The development of delayed specific drug sensitization was registered in two-thirds of the patients, which correlated with the regression of clinicobiochemical manifestations of hepatitis.


Subject(s)
Hepatitis A/immunology , Hepatitis B/immunology , Hypersensitivity, Delayed/immunology , Polysaccharides, Bacterial/therapeutic use , Prodigiozan/therapeutic use , Adolescent , Adult , Antibody Formation/drug effects , Combined Modality Therapy , Convalescence , Hepatitis A/complications , Hepatitis A/drug therapy , Hepatitis B/complications , Hepatitis B/drug therapy , Humans , Hypersensitivity, Delayed/drug therapy , Hypersensitivity, Delayed/etiology , Immunity, Cellular/drug effects , Middle Aged
7.
Eksp Klin Farmakol ; 58(5): 9-12, 1995.
Article in Russian | MEDLINE | ID: mdl-8704600

ABSTRACT

The experiments carried out on mongrel male mice showed that bacterial lipopolysaccharide Prodigiozan inhibit the activity of P-450-dependent monooxygenases of the liver, thus changing the activity of antidepressants--amitriptyline and imipraminum. The data on biological activity were tested in "tail suspension" test. Prodigiozan exhibited no central effect. Changes in biotransformation processes after single administration of both drugs resulted in the delay and prolongation of the effect. Prodigiozan prevents the induction of microsomal enzymes caused by antidepressants. Amitriptyline do not affect the immunostimulating action of prodigiozan, whereas imipraminum inhibited prodigiozan activity.


Subject(s)
Adjuvants, Immunologic/pharmacology , Amitriptyline/pharmacology , Antidepressive Agents, Tricyclic/pharmacology , Imipramine/pharmacology , Prodigiozan/pharmacology , Adjuvants, Immunologic/therapeutic use , Amitriptyline/toxicity , Animals , Antidepressive Agents, Tricyclic/toxicity , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Drug Interactions , Imipramine/toxicity , Male , Mice , Prodigiozan/therapeutic use , Pseudomonas Infections/drug therapy , Pseudomonas Infections/mortality , Sleep/drug effects , Time Factors
8.
Antibiot Khimioter ; 33(2): 131-4, 1988 Feb.
Article in Russian | MEDLINE | ID: mdl-3377603

ABSTRACT

The effect of nonsteroid antiinflammatory drugs (NAID) such as voltaren, acetylsalicylic acid, indometacin and naproxen on the efficacy of immunostimulators in treatment of infections caused by Proteus and Staphylococcus was studied. It was shown that except naproxen the NAID were capable of decreasing resistance to Proteus infections. Acetylsalicylic acid increased resistance to staphylococcal infections. The rest of the drugs did not change it. Prodigiozan increased resistance to the infections at the background of the NAID. However, volteran and indometacin lowered its effect in infections caused by Proteus. Levamisol stimulated resistance of mice to the infections at the background of volteran and increased resistance to Proteus infections lowered by acetylsalicylic acid. Methyluracyl was not able to increase resistance to the infections at the background of the NAID. It only increased resistance to Proteus infections lowered by acetylsalicylic acid. Levamisol and methyluracyl did not as a rule increase efficacy of antibiotic therapy at the background of the NAID.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Levamisole/therapeutic use , Polysaccharides, Bacterial/therapeutic use , Prodigiozan/therapeutic use , Proteus Infections/drug therapy , Uracil/analogs & derivatives , Adjuvants, Immunologic , Animals , Drug Interactions , Drug Therapy, Combination , Female , Male , Mice , Proteus Infections/immunology , Uracil/therapeutic use
9.
10.
Antibiot Khimioter ; 33(7): 532-5, 1988 Jul.
Article in Russian | MEDLINE | ID: mdl-3056303

ABSTRACT

The effect of immunomodulating therapy of adjuvant disease in rats with cyclophosphamide, prodigiozan and their combinations on infection resistance, weight of the lymphoid organs and leukocyte counts in peripheral blood, as well as the effect of prodigiozan on acute toxicity of cyclophosphamide in intact mice and mice exposed to the Freund's complete adjuvant (FCA) was studied. Prodigiozan did not increase acute toxicity of cyclophosphamide in the intact mice. It lowered the cyclophosphamide toxicity at the background of the FCA and decreased the levels of leukopenia induced by the immunosuppressor in the rats with adjuvant arthritis. It was shown on the models of local infectious inflammation caused by Proteus and lethal sepsis due to P. aeruginosa that the combined use of prodigiozan and cyclophosphamide resulted in correction of the infection resistance impairment induced by both the arthritis development and the immunosuppressor administration.


Subject(s)
Adjuvants, Immunologic , Arthritis, Experimental/drug therapy , Arthritis/drug therapy , Cyclophosphamide/therapeutic use , Polysaccharides, Bacterial/therapeutic use , Prodigiozan/therapeutic use , Animals , Arthritis, Experimental/immunology , Cyclophosphamide/toxicity , Drug Evaluation, Preclinical , Drug Interactions , Drug Therapy, Combination , Immunity, Innate/drug effects , Lethal Dose 50 , Proteus Infections/immunology , Proteus Infections/prevention & control , Proteus mirabilis , Pseudomonas Infections/immunology , Pseudomonas Infections/prevention & control , Rats
11.
Ter Arkh ; 56(10): 14-7, 1984.
Article in Russian | MEDLINE | ID: mdl-6335305

ABSTRACT

Twenty-seven patients with chronic obstructive bronchitis and 47 patients with chronic non-obstructive bronchitis were subjected to subpopulation analysis of peripheral blood immunocompetent cells. Statistically significant changes in the content of T mu and T gamma cells, killer and suppressor activity of lymphocytes were discovered in patients with chronic bronchitis. One of the immunological differences between chronic obstructive and chronic non-obstructive bronchitis lies in the activity of Con A-induced suppressors, which is appreciably lowered in patients with chronic obstructive bronchitis.


Subject(s)
Adjuvants, Immunologic/therapeutic use , B-Lymphocytes/immunology , Bronchitis/immunology , T-Lymphocytes/immunology , Adolescent , Adult , B-Lymphocytes/drug effects , Bronchitis/drug therapy , Chronic Disease , Concanavalin A/pharmacology , Drug Evaluation , Humans , Ketotifen/therapeutic use , Leukocyte Count , Levamisole/therapeutic use , Middle Aged , Prodigiozan/therapeutic use , T-Lymphocytes/drug effects
12.
Izv Akad Nauk Ser Biol ; (2): 227-34, 1993.
Article in Russian | MEDLINE | ID: mdl-8471974

ABSTRACT

Radioprotective and therapeutic effects of astazian and astazilide, the drugs of protozoan origin, were studied in comparison with known modifiers of biological reactions (bacterial polysaccharides, synthetic polypeptides) in combined radiation-thermal injuries (CRTI). The efficiency of drugs under examination was found to be time- and dose-dependent. Application of the drugs of protozoan nature 24 hours prior to or 1 hour following CRTI provided 30 to 50% survival of experimental animals for 30 days as compared to 4.5% in the group of untreated mice. Administration of the drugs 3-7 days following CRTI exerted no therapeutic effect.


Subject(s)
Burns/prevention & control , Eukaryota , Fatty Acids/therapeutic use , Glucans/therapeutic use , Polysaccharides/therapeutic use , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents/therapeutic use , Animals , Burns/drug therapy , Burns/mortality , Drug Evaluation, Preclinical , Lipopolysaccharides/therapeutic use , Luminescent Measurements , Macrophages/drug effects , Macrophages/metabolism , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Prodigiozan/therapeutic use , Pyrogens/therapeutic use , Radiation Injuries, Experimental/drug therapy , Radiation Injuries, Experimental/mortality , Time Factors
13.
Antibiot Khimioter ; 39(2-3): 36-40, 1994.
Article in Russian | MEDLINE | ID: mdl-7979793

ABSTRACT

The diagnostic laparoscopy revealed ascending multifocal affections of the chlamydial origin in the organs of the small pelvis. It provided an objective information on the tuboperitoneal inflammation and made it possible to apply the adequate treatment. The surgical laparoscopy (adhesiotomy and salpingostomy) in the comprehensive treatment with the use of doxycycline and prodigiosan promoted the recovery of the female reproductive function.


Subject(s)
Chlamydia Infections/drug therapy , Chlamydia trachomatis , Doxycycline/therapeutic use , Infertility, Female/drug therapy , Peritonitis/drug therapy , Salpingitis/drug therapy , Adult , Chlamydia Infections/complications , Chlamydia Infections/diagnosis , Chronic Disease , Drug Therapy, Combination , Female , Humans , Infertility, Female/diagnosis , Infertility, Female/etiology , Laparoscopy , Peritonitis/diagnosis , Peritonitis/etiology , Prodigiozan/therapeutic use , Salpingitis/diagnosis , Salpingitis/etiology , Tissue Adhesions
14.
Ter Arkh ; 60(11): 29-32, 1988.
Article in Russian | MEDLINE | ID: mdl-3238572

ABSTRACT

The therapeutic effectiveness of interferon inducers (prodigiozan and ibuprofen), the Soviet drug reaferon and their combined use in acute viral hepatitis type B was studied. Indications for their use resulted from lowered capacity of the body for interferonogenesis at the height of the disease. The above drugs stimulated cellular immunity, promoted more rapid disappearance of clinical symptoms of disease, and reduced the period of hospital treatment. A more marked therapeutic effect was noted in combined administration of reaferon and ibuprofen.


Subject(s)
Hepatitis B/drug therapy , Interferon Inducers/therapeutic use , Interferon Type I/therapeutic use , Acute Disease , Adolescent , Adult , Aged , Antibody Formation/drug effects , Drug Evaluation , Drug Therapy, Combination , Hepatitis B/immunology , Humans , Ibuprofen/adverse effects , Ibuprofen/therapeutic use , Immunity, Cellular/drug effects , Interferon Inducers/adverse effects , Interferon Type I/adverse effects , Interferon alpha-2 , Interferon-alpha , Middle Aged , Prodigiozan/adverse effects , Prodigiozan/therapeutic use , Recombinant Proteins
15.
Ter Arkh ; 60(3): 94-6, 1988.
Article in Russian | MEDLINE | ID: mdl-3388283

ABSTRACT

An optimum scheme of prodigiosan therapy was developed for patients with steroid-dependent bronchial asthma taking account of the hormonal and immunological status. First the drug was administered at a dose of 0.1 ml of 0.005% solution, then in 3-4 days the dose was increased (in good tolerance) up to 0.2-0.4-0.8-1.0 ml. After the first administration of the drug at a dose exceeding 0.1 ml herpes virus could be activated in the body. Course therapy producing a stimulating effect on the immune system, inhibited the occurrence of autoimmune manifestations, prolonged bronchial asthma remission, permitted the reduction of retention of a maintenance dose of glucocorticoids.


Subject(s)
Antigen-Antibody Reactions/drug effects , Asthma/drug therapy , Glucocorticoids , Polysaccharides, Bacterial/therapeutic use , Prodigiozan/therapeutic use , Substance-Related Disorders/drug therapy , Adult , Asthma/immunology , Dose-Response Relationship, Drug , Female , Humans , Hypersensitivity, Delayed/immunology , Immunity, Cellular/drug effects , Leukocytes/drug effects , Leukocytes/immunology , Male , Substance-Related Disorders/immunology , Time Factors
16.
Vopr Onkol ; 35(1): 30-4, 1989.
Article in Russian | MEDLINE | ID: mdl-2521967

ABSTRACT

Decreased levels of neutrophils, Fc- and C3-expressing receptors, oxygen-dependent metabolism as well as antibody-dependent cytotoxicity of these cells to target cells were identified in advanced chronic myeloid leukemia, particularly, in blast crisis. Treatment with cytostatic agents resulted in further decrease in said parameters. However, treatment with prodigiozan was followed by improvement in cell functioning.


Subject(s)
Adjuvants, Immunologic , Antibody-Dependent Cell Cytotoxicity/drug effects , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Neutrophils/drug effects , Polysaccharides, Bacterial/therapeutic use , Prodigiozan/therapeutic use , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Drug Evaluation , Drug Therapy, Combination , Female , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/immunology , Male , Middle Aged , Neutrophils/immunology , Receptors, Complement/drug effects , Receptors, Complement/immunology , Receptors, Complement 3b , Receptors, Fc/drug effects , Receptors, Fc/immunology
17.
Klin Med (Mosk) ; 69(3): 77-80, 1991 Mar.
Article in Russian | MEDLINE | ID: mdl-2067345

ABSTRACT

Monotherapy with reaferon (alpha 2-interferon) versus prodigiosan plus ibuprofen combination was investigated in acute viral hepatitis B. The drugs were found to stimulate cellular immunity and to induce a decrease of total serum IgE levels. The effect of prodigiosan combined with ibuprofen proved more pronounced.


Subject(s)
Hepatitis B/therapy , Interferon Type I/therapeutic use , Acute Disease , Adolescent , Adult , Aged , Drug Therapy, Combination , Hepatitis B/blood , Humans , Ibuprofen/pharmacology , Ibuprofen/therapeutic use , Interferon alpha-2 , Interferon-alpha , Middle Aged , Prodigiozan/pharmacology , Prodigiozan/therapeutic use , Recombinant Proteins
18.
Lik Sprava ; (7): 73-6, 1993 Jul.
Article in Russian | MEDLINE | ID: mdl-8209540

ABSTRACT

64 patients with infectious-allergic bronchial asthma (IABA) were examined. 20 of them were co-administered paspat, 24 patients additionally received prodigiosan, 20 patients constituted control group and were given conventional treatment. Patients of all the groups were comparable in age, state of immunological reactivity of the body and severity of the disease. Immunomodulatory effect of the drugs, mainly of paspat, not only resulted in normalization of functional properties of granulocytes but also promoted liquidation of quantitative and functional IABA-conditioned immunodeficiency on the part of T- and B-lymphocytes, thus increasing effectiveness of the treatment in the whole.


Subject(s)
Antigens, Bacterial/therapeutic use , Asthma/therapy , Prodigiozan/therapeutic use , Adolescent , Adult , Asthma/immunology , Drug Evaluation , Drug Therapy, Combination , Female , Humans , Immunity, Cellular/drug effects , Male , Middle Aged
19.
Khirurgiia (Mosk) ; (4): 86-90, 1991 Apr.
Article in Russian | MEDLINE | ID: mdl-2062077

ABSTRACT

From experience in the treatment of 326 patients with acute cholecystitis and concomitant obesity the authors discuss the causes of unfavourable outcomes and plan the means for improving the results. Postoperative suppuration of the wound occurred in 31.5% of cases, and was encountered most frequently in patients who underwent emergency and urgent operations. It was established that concomitant obesity in patients with acute cholecystitis is a factor raising the risk of postoperative pyo-inflammatory complications. The immune status was found to be significantly depressed. Preoperative immunoprophylaxis should be applied to prevent pyo-inflammatory complications after the operation.


Subject(s)
Cholecystitis/complications , Obesity/complications , Acute Disease , Adult , Aged , Cholecystectomy , Cholecystitis/immunology , Cholecystitis/surgery , Emergencies , Female , Humans , Levamisole/therapeutic use , Male , Middle Aged , Obesity/immunology , Postoperative Complications/prevention & control , Prodigiozan/therapeutic use
20.
Lik Sprava ; (10-12): 45-7, 1993.
Article in Russian | MEDLINE | ID: mdl-8030307

ABSTRACT

Influence of various patterns of immunocorrective therapy on clinical course of chronic myeloleukemia (CML) was studied. It was shown that combinations of drugs with different pharmacological effects provide more than 5-fold decrease in incidence of infection-related complications and promote rapid recovery from infections during antibacterial treatment.


Subject(s)
Immunotherapy/methods , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy , Adjuvants, Immunologic/therapeutic use , Biological Products/therapeutic use , Combined Modality Therapy , Drug Combinations , Drug Evaluation , Drug Therapy, Combination , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/immunology , Peptides/therapeutic use , Prodigiozan/therapeutic use , Thymus Extracts/therapeutic use , Yeast, Dried/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL